FDA Inspection 1119012 — Biomat USA Inc
The FDA completed an inspection of Biomat USA Inc on January 15, 2020 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 15, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Birmingham, AL (United States)